What’s New?
Due to the Covid-19 pandemic, the diagnosis of renal cell carcinoma incidentally diagnosed is decreasing. There are serious reductions in the number of surgeries performed for RCC. It is likely that there will be an increase in the rates of advanced and metastatic RCC in the following periods.